Latest Biotech News

Biopharma deal activity outside M&As has surged to record levels in the first seven months of 2025, reaching $164 billion, reflecting strong investment despite a continuing drought in IPOs to...

Schrödinger has halted development of its CDC7 inhibitor SGR-2921, an experimental cancer drug, following two patient deaths in a Phase I trial involving acute myeloid leukemia (AML) and high-risk...

A Phase 1 clinical study published in Cancer Cell highlights a novel Fc-optimized CD40 agonistic antibody delivered intratumorally with promising efficacy in metastatic cancer patients. Among 12...

Cutting-edge advances in artificial intelligence are transforming biotechnology research workflows. Innovations include a new technology accelerating biological data generation for AI training...

Neuroscientists have developed an innovative brain-computer interface (BCI) that enables communication through decoding imagined speech. Unlike traditional BCIs requiring attempted speech, this...

The U.S. Food and Drug Administration (FDA) has granted a swift, full approval to Precigen Inc.'s gene therapy, Papzimeos (zopapogene imadenovec), for treating adults with recurrent respiratory...

Pfizer announced that inclacumab, a sickle cell disease drug candidate acquired from Global Blood Therapeutics, failed to meet its primary endpoint in a Phase 3 clinical study. The candidate did...

Elysium Therapeutics is advancing a novel therapeutic approach to address opioid overdose through its Synthetic Opioid Overdose Prevention and Reversal (SOOPR) program. The investigational...

Researchers have engineered a brain-computer interface (BCI) system that allows users to communicate by decoding neural signals associated with inner speech, rather than attempted speech....

Researchers at the Massachusetts Institute of Technology (MIT) have utilized generative artificial intelligence (AI) to design novel antibiotic compounds targeting highly resistant bacteria such...

Schrödinger has discontinued development of its CDC7 inhibitor drug candidate, SGR-2921, following the deaths of two patients with acute myeloid leukemia (AML) during a phase I dose-escalation...

Eli Lilly announced plans to significantly increase the list prices of its drugs, including the weight-loss medication Mounjaro, across European markets such as the United Kingdom. This strategic...

The U.S. Department of Health and Human Services (HHS) has announced the reinstatement of the long-defunct Task Force on Safer Childhood Vaccines, originally disbanded in 1998. This move follows a...

Scientists at the University of Cologne have innovated on the CUT&Tag chromatin accessibility assay by optimizing buffer salt concentrations, enabling the detection of transcription factor binding...

Researchers at the Institute for Bioengineering of Catalonia, in collaboration with Dexeus University Hospital, have successfully recorded, for the first time, the three-dimensional real-time...

The U.S. Department of Health and Human Services has reinstated the Task Force on Safer Childhood Vaccines, a panel originally disbanded in 1998, aiming to improve vaccine safety and oversight for...

Precigen Inc. received swift full FDA approval for Papzimeos (zopapogene imadenovec), a gene therapy treating recurrent respiratory papillomatosis (RRP), characterized by benign respiratory tract...

Eli Lilly plans steep price increases for its weight-loss drug Mounjaro in the U.K., raising the highest dose price by 170%, aiming to lower U.S. prices amidst pressure from the Trump...

Researchers at MIT employed generative artificial intelligence to design novel antibiotic compounds effective against multidrug-resistant Neisseria gonorrhoeae and MRSA. Screening millions of...

Schrödinger discontinued its CDC7 inhibitor SGR-2921 development following the deaths of two AML patients in a Phase I trial. Despite promising preclinical and early monotherapy activity, safety...